Manipal Health Raises ₹4,167 Crore From Anchor Investors

Manipal Health Enterprises has raised ₹4,167 crore from anchor investors ahead of its ₹9,275-crore initial public offering, which opened for public subscription on Wednesday.

The company allotted more than 7.06 crore shares to anchor investors at ₹590 each, the upper end of the IPO price band. Participants in the anchor round included prominent international investors such as Abu Dhabi Investment Authority, Allianz Global Investors Fund, and Goldman Sachs Bank Europe, as well as domestic mutual funds like ICICI Prudential Mutual Fund and Kotak Mutual Fund.

The IPO received 6 percent subscription in the initial hours, according to NSE data available until 1.30 pm. The three-day public issue will close on July 31.

Manipal Health has fixed a price band of ₹560-590 per share. At the upper end, the company will be valued at over ₹77,600 crore. The IPO includes a fresh issue of shares worth up to ₹8,000 crore and an offer for sale of up to 2.16 crore shares by promoters and existing investors.

The company plans to use ₹5,378 crore from the fresh issue to repay or prepay borrowings of its subsidiary, Manipal Hospitals. Another ₹574 crore will be used to acquire a minority stake in Sahyadri Hospitals, while the remaining amount will support general corporate needs.

Manipal Health runs a network of multispeciality hospitals providing outpatient, tertiary and quaternary healthcare services. As of March 31, 2026, it operated 49 hospitals across India with 13,037 licensed beds. During FY26, the company reported revenue from operations of ₹10,336 crore and a profit of ₹916.52 crore.

The company's shares are expected to list on the BSE and NSE on or around August 5.

The successful raising of funds from anchor investors and the opening of the public issue mark significant steps for Manipal Health as it seeks to expand its operations and strengthen its position in the healthcare sector.

In the context of India's growing healthcare needs, Manipal Health's IPO is seen as a major development. The company's plans to use the funds raised to repay debt and acquire new assets are expected to support its long-term growth strategy.

Overall, Manipal Health's IPO is a notable event in India's healthcare and financial sectors, and its success will be closely watched by investors and industry observers alike.

The listing of Manipal Health's shares on the BSE and NSE is expected to provide a significant boost to the company's profile and visibility, and will likely have a positive impact on the Indian healthcare sector as a whole.

In terms of significance for Mumbai and India, Manipal Health's IPO highlights the growing importance of the healthcare sector in the country's economy. The company's expansion plans and commitment to providing high-quality healthcare services are expected to contribute to the growth and development of the sector, and will likely have a positive impact on the lives of millions of Indians.

The IPO also underscores the growing interest of international investors in India's healthcare sector, and the potential for Indian companies to raise significant funds from global investors.

In conclusion, Manipal Health's ₹9,275-crore IPO is a major development in India's healthcare and financial sectors, and its success will have significant implications for the company, the sector, and the country as a whole.